ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
4,325
Screening encounters
5,237
Diagnostic referrals
1,002
Outstanding pathways
324

Screening pathway

  1. Screening5,237Encounters
  2. Positive finding1,825Documented findings
  3. Referral1,002Diagnostic referrals
  4. Follow-up1,227Diagnostic visits
  5. Outcome678Resolved pathways

Stage totals use different units. Pending pathways: 324. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 2135 · EXP-2135Synthetic · Site E

Full participant history through 2027-03-22, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-04-26
  4. · Diagnostic referral · EXP-2135-T-R
  5. · Barrier documented · Contact difficulty
  6. · Contact attempt · Unsuccessful
  7. · Diagnostic booking · Initial booking
  8. · Contact attempt · Reached
  9. · Diagnostic visit · Missed
  10. · Diagnostic booking · Rebooking
  11. · Diagnostic visit · Attended
  12. · Diagnosis · Colposcopy · Biopsy collected
  13. · Diagnosis · Histopathology · No high-grade lesion identified
  14. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2027-01-23
  15. · Follow-up disposition · Resolved · EXP-2135-T-R
  16. · Screening · HPV DNA · Repeat · Prior VIA positive
  17. · Screening result · HPV DNA · HPV detected · Adequate
  18. · Surveillance · HPV DNA · Surveillance · After clinical assessment
  19. · Surveillance result · HPV DNA · HPV detected · Adequate

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

4325 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-2014 · Expanded synthetic participant 2014Site E — Resource-Constrained Navigation Programme
EXP-2015 · Expanded synthetic participant 2015Site E — Resource-Constrained Navigation Programme
EXP-2016 · Expanded synthetic participant 2016Site B — Peri-Urban Access Programme
EXP-2017 · Expanded synthetic participant 2017Site D — Community Engagement Programme
EXP-2018 · Expanded synthetic participant 2018Site C — Rural Outreach Programme
EXP-2019 · Expanded synthetic participant 2019Site C — Rural Outreach Programme
EXP-2020 · Expanded synthetic participant 2020Site E — Resource-Constrained Navigation Programme
EXP-2021 · Expanded synthetic participant 2021Site C — Rural Outreach Programme
EXP-2022 · Expanded synthetic participant 2022Site D — Community Engagement Programme
EXP-2023 · Expanded synthetic participant 2023Site A — Urban Referral Hub
EXP-2024 · Expanded synthetic participant 2024Site A — Urban Referral Hub
EXP-2025 · Expanded synthetic participant 2025Site D — Community Engagement Programme
EXP-2026 · Expanded synthetic participant 2026Site B — Peri-Urban Access Programme
EXP-2027 · Expanded synthetic participant 2027Site D — Community Engagement Programme
EXP-2028 · Expanded synthetic participant 2028Site B — Peri-Urban Access Programme
EXP-2029 · Expanded synthetic participant 2029Site D — Community Engagement Programme
EXP-2030 · Expanded synthetic participant 2030Site E — Resource-Constrained Navigation Programme
EXP-2031 · Expanded synthetic participant 2031Site E — Resource-Constrained Navigation Programme
EXP-2032 · Expanded synthetic participant 2032Site B — Peri-Urban Access Programme
EXP-2033 · Expanded synthetic participant 2033Site C — Rural Outreach Programme
EXP-2034 · Expanded synthetic participant 2034Site B — Peri-Urban Access Programme
EXP-2035 · Expanded synthetic participant 2035Site C — Rural Outreach Programme
EXP-2036 · Expanded synthetic participant 2036Site D — Community Engagement Programme
EXP-2037 · Expanded synthetic participant 2037Site B — Peri-Urban Access Programme
EXP-2039 · Expanded synthetic participant 2039Site D — Community Engagement Programme

Programme insights

Encounters by modality

VIA
1958
HPV DNA
2559
Cytology
720

Navigation activity

Barrier documented
913
Contact attempt
1463
Navigation intervention
403
Diagnostic booking
1260
Diagnostic visit
1227

Documented barriers

Contact difficulty
291
Transport difficulty
301
Appointment coordination
321

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.